Q2 2020 Holdings
Filed 2020-08-14 | 93 holdings | $279.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centene Corp del(CNC) | COM | 15135B101 | $56.3M | 886,000 | 20.2% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $41.0M | 13,910,899 | 14.7% |
| Alector Inc(ALEC) | COM | 014442107 | $41.0M | 1,676,997 | 14.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $33.8M | 1,008,656 | 12.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $22.6M | 536,001 | 8.1% |
| Adapthealth Corp(AHCO) | COM CL A | 00653Q102 | $22.4M | 1,389,341 | 8.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $21.2M | 4,456,519 | 7.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $17.7M | 2,561,554 | 6.4% |
| Cerus Corp(CERS) | COM | 157085101 | $14.6M | 2,204,700 | 5.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $5.2M | 464,252 | 1.9% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $280.6K | $144,832,000 | 0.1% |
| Mylan NV | SHS EURO | N59465109 | $195.4K | 12,151,362 | 0.1% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $157.8K | $115,776,000 | 0.1% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $123.3K | 1,346,167 | 0.0% |
| DFP Healthcare Acquisitns Co | UNIT 03/31/2025 | 23343Q209 | $111.7K | 10,460,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $108.4K | 1,951,211 | 0.0% |
| Nuvasive Inc | NOTE 2.250% 3/1 | 670704AG0 | $93.1K | 85,000,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $90.8K | 2,561,000 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $87.3K | 1,663,000 | 0.0% |
| Dexcom Inc | NOTE 0.750%12/0 | 252131AH0 | $84.3K | 34,000,000 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $78.1K | 1,370,186 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $68.0K | 704,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $67.1K | 3,448,912 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $66.1K | 5,144,539 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $59.3K | 61,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $56.7K | 1,796,383 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $55.1K | 2,470,013 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $51.8K | 1,234,262 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $49.5K | 1,408,603 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $44.0K | $49,064,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $43.6K | 7,259,988 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $43.4K | $57,791,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $42.7K | 278,085 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $42.3K | 3,057,161 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $40.8K | 261,765 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $40.2K | 421,619 | 0.0% |
| Meridian Bioscience Inc(MR4) | COM | 589584101 | $38.7K | 1,663,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $34.9K | 2,576,879 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $34.3K | 1,158,841 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $33.6K | 874,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $31.6K | 405,386 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $31.4K | 913,775 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $31.2K | 744,998 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $29.4K | 5,767,409 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $28.9K | $24,877,000 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $28.5K | 6,545,500 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $26.3K | 873,890 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $25.2K | 421,679 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $24.9K | 1,186,215 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $24.8K | 877,011 | 0.0% |